The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

The recombinant protein vaccine, dubbed GSK3943104, did not meet the study’s primary efficacy objective. GSK added that the ...

The First in China! BLA Submitted for Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026 HONG KONG ...

Around the world, more than a dozen intranasally delivered COVID-19 vaccines have entered clinical trials, and they run the gamut from adenovirus-vectored genes for viral antigens to recombinant ...

Founded in 1987 in the US, Gale Smith – VP of vaccine development at Novavax – invented the technique of using insect cells for producing recombinant protein vaccines. A further milestone came ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

A variety of vaccine approaches, however, have been investigated using both inactivated virus and recombinant DNA technology. These approaches will be further discussed later in this review.

The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.